Patients should be the tipping point of individualizing breast cancer surgery: Commentary on 'Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges'

Ann Oncol. 2020 Sep;31(9):1264. doi: 10.1016/j.annonc.2020.05.021. Epub 2020 May 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / surgery
  • Humans
  • Mastectomy
  • Mastectomy, Segmental
  • Neoadjuvant Therapy*